Lv6
2580 积分 2023-12-20 加入
IL-7: Comprehensive review
1个月前
已完结
Flip the coin: IL-7 and IL-7R in health and disease
1个月前
已完结
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα
1个月前
已完结
A mechanism for the initiation of allergen-induced T helper type 2 responses
2个月前
已完结
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα
3个月前
已完结
RNA chemistry and therapeutics
3个月前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
3个月前
已完结
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers
3个月前
已完结
GPCR drug discovery: new agents, targets and indications
3个月前
已完结
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
3个月前
已完结
皖公网安备34019202002308
